Incomplete Revascularization in the Long Term

Original Title: Long-Term Outcome of Incomplete Revascularization after Percutaneous Coronary Intervention in SCAAR (Swedish Coronary Angiography and Angioplasty Registry). Reference: Kristina Hambraeus et al. J Am Coll Cardiol Intv. 2016;9(3):207-215.

 

The aim of this study was to describe the evolution of patients with multivessel disease undergoing PCI with incomplete revascularization, and its probable association to death, repeat revascularization and MI in the long term.

Between 2006 and 2010 23342 patients with multivessel disease were identified in the SCAAR registry (Swedish Coronary Angiography and Angioplasty Registry). Incomplete revascularization was defined as any vessel with a lesion larger than 60% irrigating at least 10% of the myocardium.

Patients with incomplete revascularization (n = 15,165) were older, with more extensive coronary disease and often had STEMI at presentation, compared to those with complete revascularization (n = 8,177).

At one year, all cause mortality, AMI and repeat revascularization rates were higher among the incomplete revascularization patients, compared to those with complete revascularization (7.1% vs 3.8%, 10.4% vs 6.0% and 20.5% vs 8.5%, respectively).

After propensity score matching, the adjusted risk at one year for the composite of death, MI or revascularization was significantly higher for the incomplete revascularization group. (HR 2.12 CI 95% 1.98 to 2.28; p < 0.0001).

The adjusted risk of death and the combination of death/MI also resulted higher for the incomplete revascularization group with 1.29 (CI 95% 1.12 to 1.49; p=0.0005) and 1.42 (CI 95% 1.30 to 1.56; p<0.0001), respectively.

Conclusion
Incomplete revascularization at discharge in patients with multivessel disease undergoing PCI is associated with a high risk of adverse cardiac events at one year.

Editorial Comment
So far, the evidence is conflictive and generally indirect. Even though this study provides important data, is limited by its retrospective character and by the fact that it was carried out in different populations, which required several adjustments for researchers to be able to compare. Clearly, in almost all studies, patients with incomplete revascularization are always at higher risk, and their treatment was determined by the impossibility to receive a complete revascularization, rather than by choice.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....